MARKET

TENX

TENX

Tenax Therapeutics Inc
NASDAQ
16.95
-0.43
-2.47%
Opening 13:38 07/08 EDT
OPEN
17.07
PREV CLOSE
17.38
HIGH
17.83
LOW
16.73
VOLUME
663.91K
TURNOVER
--
52 WEEK HIGH
18.38
52 WEEK LOW
5.68
MARKET CAP
449.60M
P/E (TTM)
-12.1167
1D
5D
1M
3M
1Y
5Y
1D
Tenax Therapeutics: 'Hold' TNX-103 Data August 2026 - But With Caution Ahead
Seeking Alpha · 2d ago
LifeSci Capital Reaffirms Their Buy Rating on Tenax Therapeutics (TENX)
TipRanks · 2d ago
Weekly Report: what happened at TENX last week (0629-0703)?
Weekly Report · 2d ago
Tenax Therapeutics grants 160,000 inducement stock options to new hires
PUBT · 6d ago
Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday
Benzinga · 6d ago
Tenax Therapeutics Price Target Maintained With a $27.00/Share by Chardan Capital
Dow Jones · 6d ago
Tenax Therapeutics Is Maintained at Buy by Chardan Capital
Dow Jones · 6d ago
Three Years of War Changed What Governments Buy. One Player is Already Winning Contracts (NASDAQ: MDWD)
TipRanks · 6d ago
More
About TENX
Tenax Therapeutics, Inc. is a Phase 3 development-stage pharmaceutical company. The Company is focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The Company's products include TNX-201 (oral enteric-coated imatinib) and TNX-103 (oral levosimendan). The Company is developing dosing and a formulation of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension (PAH). The Company’s other programs include TNX-101 and TNX-102. Levosimendan is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. The Company has completed the Phase II trial of levosimendan in patients with PH and heart failure with preserved ejection fraction (HFpEF).

Webull offers Tenax Therapeutics Inc stock information, including NASDAQ: TENX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TENX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TENX stock methods without spending real money on the virtual paper trading platform.